537. Deputy Richard Boyd Barrett asked the Minister for Health if the approval of the drugs Nivolumab and Pembrolizumab will be expedited in order to prolong the life of certain cancer patients and in particular in the case of a person (details supplied); if they will be made VAT exempt and tax allowable in the circumstances in which a patient has no option but to self fund these drugs; and if he will make a statement on the matter. [30314/18]

Summary

537. Deputy Richard Boyd Barrett asked the Minister for Health if the approval of the drugs Nivolumab and Pembrolizumab will be expedited in order to prolong the life of certain cancer patients and in particular in the case of a person (details supplied); if they will be made VAT exempt and tax allowable in the circumstances in which a patient has no option but to self fund these drugs; and if he will make a statement on the matter. [30314/18]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Reimbursement

  xml · EN · 10 July 2018

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.